Contact
searchSearch
HMP Global
Login

Endometrial Cancer News

News
FDA Approves Dostarlimab-gxly With Chemotherapy for Patients With Endometrial Cancer
08/16/2023
In July 2023, the FDA approved dostarlimab-gxly with carboplatin and paclitaxel for the treatment of advanced endometrial cancer in adult patients.
In July 2023, the FDA approved dostarlimab-gxly with carboplatin and paclitaxel for the treatment of advanced endometrial cancer in adult patients.
In July 2023, the FDA approved...
08/16/2023
Journal of Clinical Pathways
News
The Medicaid Expansion’s Impact on Affordable Care: Did it Increase the Number of Patients Receiving Adjuvant Radiation Treatment?
08/02/2023
Researchers conducted a study on the number of patients with endometrial cancer who received adjuvant radiation treatment in the states that implemented further Medicaid expansion.
Researchers conducted a study on the number of patients with endometrial cancer who received adjuvant radiation treatment in the states that implemented further Medicaid expansion.
Researchers conducted a study on...
08/02/2023
Journal of Clinical Pathways
News
Study Analyzes Adjuvant Chemoradiotherapy vs Adjuvant Chemotherapy for Patients with Stage III Endometrial Cancer Following Radical Surgery
04/19/2023
Si-yu Cao, MD, Department of Gynecology and Obstetrics, West China Second Hospital, Sichuan University, Sichuan, China, and colleagues recently compared the effectiveness of adjuvant chemoradiotherapy (ACR) to adjuvant chemotherapy (AC) for...
Si-yu Cao, MD, Department of Gynecology and Obstetrics, West China Second Hospital, Sichuan University, Sichuan, China, and colleagues recently compared the effectiveness of adjuvant chemoradiotherapy (ACR) to adjuvant chemotherapy (AC) for...
Si-yu Cao, MD, Department of...
04/19/2023
Journal of Clinical Pathways
News
Beyond Immunotherapy Treatment for Patients With Recurrent Metastatic Endometrial Cancer
04/14/2023
At the 2023 ESMO Gynecological Cancers Congress in Barcelona, Spain, Mansoor Raza Mirza, MD, a clinical oncologist from Rigshospitalet in Denmark, presented data on nonimmunological achievements and the role of HER2, B53, and other molecular...
At the 2023 ESMO Gynecological Cancers Congress in Barcelona, Spain, Mansoor Raza Mirza, MD, a clinical oncologist from Rigshospitalet in Denmark, presented data on nonimmunological achievements and the role of HER2, B53, and other molecular...
At the 2023 ESMO Gynecological...
04/14/2023
Journal of Clinical Pathways
News
The Effectiveness of a Ferroptosis-Related lncRNA Model Based on CFAP58-DT for Predicting Prognosis in Endometrial Cancer
03/17/2023
Aijun Qin, MD, and colleagues recently investigated the use of a prognostic ferroptosis-related long noncoding RNA (lncRNA) model based on the RNA gene CFAP58-DT for predicting the survival time of patients with endometrial cancer and to help...
Aijun Qin, MD, and colleagues recently investigated the use of a prognostic ferroptosis-related long noncoding RNA (lncRNA) model based on the RNA gene CFAP58-DT for predicting the survival time of patients with endometrial cancer and to help...
Aijun Qin, MD, and colleagues...
03/17/2023
Journal of Clinical Pathways
News
Costs Among Patients With Endometrial Cancer Receiving Postoperative Hemoglobin Level Testing Following Robotic-assisted Hysterectomy
05/18/2022
Findings from a recent study suggest that postoperative hemoglobin testing may be safely avoided unless starting hemoglobin is
Findings from a recent study suggest that postoperative hemoglobin testing may be safely avoided unless starting hemoglobin is
Findings from a recent study...
05/18/2022
Journal of Clinical Pathways
News
Are Gene-Specific Strategies Cost-Effective for Reducing Gynecologic Cancer Risk in Women With Lynch Syndrome?
09/21/2021
Findings from a cost-effectiveness analysis support gene-specific surveillance and preventative strategies for reducing gynecologic cancer risk in women with Lynch syndrome.
Findings from a cost-effectiveness analysis support gene-specific surveillance and preventative strategies for reducing gynecologic cancer risk in women with Lynch syndrome.
Findings from a...
09/21/2021
Journal of Clinical Pathways
News
Safety and Cost-Effectiveness of Implementing Presurgical Testing Guidelines for Endometrial Cancer
08/11/2021
The use of presurgical testing guidelines for patients with endometrial pathology undergoing hysterectomy in the ambulatory setting is safe and cost-effective.
The use of presurgical testing guidelines for patients with endometrial pathology undergoing hysterectomy in the ambulatory setting is safe and cost-effective.
The use of presurgical testing...
08/11/2021
Journal of Clinical Pathways
JCP September/October 2024 Issue

Current Issue

October 2024
Volume 10
Issue 5
Current Issue
Issue Archive

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Subscribe

Journal of Clinical Pathways Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use